Cargando…

Effect of coadministration of omega-3 fatty acids with glimepiride on glycemic control, lipid profile, irisin, and sirtuin-1 in type 2 diabetes mellitus patients: a randomized controlled trial

BACKGROUND AND OBJECTIVE: Type 2 diabetes mellitus (T2DM) is caused by insulin resistance or tissue insensitivity to insulin, as well as relative insulin insufficiency. Diabetes that is uncontrolled for an extended period of time is linked to substantial comorbidities and organ damage. The purpose o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Werida, Rehab H., Ramzy, Aalaa, Ebrahim, Youssri Nassief, Helmy, Maged Wasfy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675938/ https://www.ncbi.nlm.nih.gov/pubmed/38001474 http://dx.doi.org/10.1186/s12902-023-01511-2

Ejemplares similares

Folic acid effect on homocysteine, sortilin levels and glycemic control in type 2 diabetes mellitus patients
por: El-khodary, Noha M., et al.
Publicado: (2022)

Comparative study of Dapagliflozin versus Glimepiride effect on insulin regulated aminopeptidase (IRAP) and interleukin-34 (IL-34) in patient with type 2 diabetes mellitus
por: Zekry, Rania, et al.
Publicado: (2023)

Author Correction: Comparative study of Dapagliflozin versus Glimepiride effect on insulin regulated aminopeptidase (IRAP) and interleukin-34 (IL-34) in patient with type 2 diabetes mellitus
por: Zekry, Rania, et al.
Publicado: (2023)

Circulating IL-6, clusterin and irisin in obese subjects with different grades of obesity: association with insulin resistance and sexual dimorphism
por: Werida, Rehab H., et al.
Publicado: (2021)

Possible effects of glimepiride beyond glycemic control in patients with type 2 diabetes: a preliminary report
por: Nakamura, Ikuko, et al.
Publicado: (2014)

Irisin Precursor FNDC5 and Glycemic Control in Patients With Type 2 Diabetes
por: Lima Mágero, Felipe Rodrigues, et al.
Publicado: (2021)

Accelerated Insulin Pharmacokinetics and Improved Postprandial Glycemic Control in Patients With Type 1 Diabetes After Coadministration of Prandial Insulins With Hyaluronidase
por: Hompesch, Marcus, et al.
Publicado: (2011)

Adding glimepiride to current insulin therapy increases high-molecular weight adiponectin levels to improve glycemic control in poorly controlled type 2 diabetes
por: Li, Chun-Jun, et al.
Publicado: (2014)

Comparison of the efficacy of sitagliptin and glimepiride dose‐up in Japanese patients with type 2 diabetes poorly controlled by sitagliptin and glimepiride in combination
por: Shimoda, Seiya, et al.
Publicado: (2013)

Challenges for Effective Glycemic control in T2DM during Covid-19 pandemic and Use of Glimepiride/Metformin FDC: Opinion from Indian Clinicians
por: Gandhi, Alka, et al.
Publicado: (2022)

The effect of doxycycline on neuron-specific enolase in patients with traumatic brain injury: a randomized controlled trial
por: Mansour, Noha O., et al.
Publicado: (2021)

Dapagliflozin Added to Glimepiride in Patients with Type 2 Diabetes Mellitus Sustains Glycemic Control and Weight Loss Over 48 Weeks: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial
por: Strojek, Krzysztof, et al.
Publicado: (2014)

Effect of amlodipine versus bisoprolol in hypertensive patients on maintenance hemodialysis: A randomized controlled trial
por: Youssef, Ahmed Mohamed, et al.
Publicado: (2021)

Association of circulating irisin levels with normal weight obesity, glycemic and lipid profile
por: Mehrabian, Sarvenaz, et al.
Publicado: (2016)

Formulation design and development of matrix diffusion controlled transdermal drug delivery of glimepiride
por: Akram, Muhammad Rouf, et al.
Publicado: (2018)

In Addition to Poor Glycemic Control, a High Level of Irisin in the Plasma Portends Early Cognitive Deficits Clinically in Chinese Patients With Type 2 Diabetes Mellitus
por: Lin, Hongyan, et al.
Publicado: (2019)

Comparative efficacy of glimepiride and metformin in monotherapy of type 2 diabetes mellitus: meta-analysis of randomized controlled trials
por: Zhu, Hongmei, et al.
Publicado: (2013)

Epigenetic restoration and activation of ERβ: an inspiring approach for treatment of triple-negative breast cancer
por: Salahuddin, Ahmad, et al.
Publicado: (2022)

Glimepiride monotherapy versus combination of glimepiride and linagliptin therapy in patients with HNF1A-diabetes: a protocol for a randomised, double-blinded, placebo-controlled trial
por: Sidelmann Christensen, Alexander, et al.
Publicado: (2018)

Sirtuins and Hypoxia in EMT Control
por: Aventaggiato, Michele, et al.
Publicado: (2022)

Formulation and characterization of orodispersible tablet of glimepiride
por: Kinani, Ahmad AB Yosef, et al.
Publicado: (2022)

BK Viremia Exacerbation With Adalimumab Coadministration
por: Lum, Erik L., et al.
Publicado: (2020)

Ertugliflozin Compared with Glimepiride in Patients with Type 2 Diabetes Mellitus Inadequately Controlled on Metformin: The VERTIS SU Randomized Study
por: Hollander, Priscilla, et al.
Publicado: (2017)

A controlled trial of quetiapine XR coadministration treatment of SSRI-resistant panic disorder
por: Goddard, Andrew W., et al.
Publicado: (2015)

Coadministration of Nematophagous Fungi for Biological Control over Nematodes in Bovine in the South-Eastern Brazil
por: Luns, Fábio Dias, et al.
Publicado: (2018)

Role of alpha-lipoic acid in counteracting paclitaxel- and doxorubicin-induced toxicities: a randomized controlled trial in breast cancer patients
por: Werida, Rehab H., et al.
Publicado: (2022)

Leflunomide abrogates neuroinflammatory changes in a rat model of Alzheimer’s disease: the role of TNF-α/NF-κB/IL-1β axis inhibition
por: Nafea, Menna, et al.
Publicado: (2022)

The Effects of Lactobacillus casei on Glycemic Response, Serum Sirtuin1 and Fetuin-A Levels in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial
por: Khalili, Leila, et al.
Publicado: (2019)

Relationship between serum irisin, glycemic indices, and renal function in type 2 diabetic patients
por: Mahmoodnia, Leila, et al.
Publicado: (2016)

Glimepiride-induced cholestasis in a man with diabetes mellitus: a case report
por: Omar, Hesham, et al.
Publicado: (2009)

Glimepiride: evidence-based facts, trends, and observations
por: Basit, Abdul, et al.
Publicado: (2012)

Formulation and Evaluation of New Glimepiride Sublingual Tablets
por: Al-Madhagi, Wafa, et al.
Publicado: (2017)

Erratum: Formulation and characterization of orodispersible tablet of glimepiride
Publicado: (2023)

Effect of centchroman coadministration on the pharmacokinetics of metformin in rats
por: Lal, Jawahar, et al.
Publicado: (2010)

Hemodynamic effect of avanafil and glyceryl trinitrate coadministration
por: Swearingen, Dennis, et al.
Publicado: (2013)

Rationale, design and baseline characteristics of a 4-year (208-week) phase III trial of empagliflozin, an SGLT2 inhibitor, versus glimepiride as add-on to metformin in patients with type 2 diabetes mellitus with insufficient glycemic control
por: Ridderstråle, Martin, et al.
Publicado: (2013)

Serum sclerostin and irisin as predictive markers for atherosclerosis in Egyptian type II diabetic female patients: A case control study
por: Saadeldin, Mona Kamal, et al.
Publicado: (2018)

Role of neopterin as an inflammatory biomarker in congestive heart failure with insights on effect of drug therapies on its level
por: Dogheim, Gaidaa M., et al.
Publicado: (2022)

Functional capacity and inflammatory biomarkers as predictors for right atrial volume index in COPD patients
por: Khedr, Lamiaa, et al.
Publicado: (2023)

Irisin Is Controlled by Farnesoid X Receptor and Regulates Cholesterol Homeostasis
por: Li, Hong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cpa34h2rg5l5hc9ihol2lnvkjm